At this time, Neurosearch is working with the following experienced Central Institutional Review Boards:
Western Coast Quantum Quorum Copernicus Schulman Chesapeake
Each of these central IRB's have been utilized, at the discretion of industry partners, to assist us in achieving an efficient study start-up.
We seek to provide Phase II-IV clinical trial involvement in the following specialty clinical areas:
Parkinson's Disease related treatments Movement Disorder related treatments Multiple Sclerosis treatments Alzhemier's Disease related treatments Stroke treatments
Ideally, Neurosearch would be an outpatient study site; however limited inpatient responsibility is acceptable at the institution of our choosing and only as the first stage of a study, such as the surgical implantation of a dose of gene therapy or an implantable device that is part of a study.